+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype



Dual therapy with statins and antioxidants is superior to statins alone in decreasing the risk of cardiovascular disease in a subgroup of middle-aged individuals with both diabetes mellitus and the haptoglobin 2-2 genotype



Arteriosclerosis, Thrombosis, and Vascular Biology 28(3): E18-E20




(PDF emailed within 0-6 h: $19.90)

Accession: 052727186

Download citation: RISBibTeXText

PMID: 18296583

DOI: 10.1161/ATVBAHA.107.159905


Related references

Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arteriosclerosis, Thrombosis, and Vascular Biology 28(2): 341-347, 2007

Vitamin E reduces cardiovascular disease in individuals with diabetes mellitus and the haptoglobin 2-2 genotype. Pharmacogenomics 11(5): 675-684, 2010

The clinical biochemistry of hypo-lipedemic therapy and mechanisms of action of statins: the fatty acids, statins and diabetes mellitus. Klinicheskaia Laboratornaia Diagnostika 2014(2): 4-15, 2014

Unanswered questions: the use of statins in older people to prevent cardiovascular event effects of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. Journal of the American Geriatrics Society 50(2): 391-393, 2002

Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. American Journal of Health-System Pharmacy 64(15): 1603-1610, 2007

US panel recommends statins for adults aged 40 to 75 at 10% or greater risk of cardiovascular disease. Bmj 351: H7008, 2016

Statins and risk of new-onset diabetes mellitus: is there a rationale for individualized statin therapy?. American Journal of Cardiovascular Drugs 14(2): 79-87, 2014

Statins Ineffective for Primary Prevention of Cardiovascular Disease in Patients 75 Years or Older Without Diabetes Mellitus. American Family Physician 99(7): 461, 2019

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population. Archives of Gerontology and Geriatrics 29(2): 175-182, 2004

Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: A study on a middle-aged and elderly population. Archives of Gerontology & Geriatrics 29(2): 175-182, 1999

Risk of diabetes mellitus associated with disease-modifying antirheumatic drugs and statins in rheumatoid arthritis. Annals of the Rheumatic Diseases 76(5): 848-854, 2016

Statins and cardiovascular diseases: The multiple effects of lipid-lowering therapy by statins. Atherosclerosis 153(1): 181-189, 2000

Use of statins and gemfibrozil in patients with type 2 diabetes mellitus and cardiovascular risk factors attending adult day health care centers: an opportunity for pharmacists. Consultant Pharmacist 22(1): 38-44, 2007

LIFESTAT - Living with statins: An interdisciplinary project on the use of statins as a cholesterol-lowering treatment and for cardiovascular risk reduction. Scandinavian Journal of Public Health 44(5): 534-539, 2017

Statins: cardiovascular risk reduction in percutaneous coronary intervention-basic and clinical evidence of hyperacute use of statins. International Journal of Hypertension 2011: 904742, 2011